Cancer fact sheets [Internet]. Global Cancer Observatory. International Agency for Research on Cancer. Lyon, France. A [Cited 24 Sep 2019]. 2019 Available from: https://gco.iarc.fr/today/fact-sheets-cancers

Gupta S. Breast cancer: Indian experience, data, and evidence. South Asian J Cancer. 2016;5(03):085–6.

Article  CAS  Google Scholar 

Najafi S, Sadeghi M, Abasvandi F, Shajari MR, Mohebi K, Ghandchi H. Prognostic factors influencing prognosis in early breast cancer patients. Prz Menopauzalny. 2019;18(2):82–8.

CAS  PubMed  PubMed Central  Google Scholar 

Cancer fact sheets [Internet]. Global Cancer Observatory (2019). International Agency for Research on Cancer. Lyon, France. A [Cited 24 Sep 2019]. Available from: http://gco.iarc.fr/today/ data/factsheets/populations/356- india-fact-sheets.pdf

Gangane N. Population based Cancer Registry of Wardha District. National Cancer Registry Programme, Indian Council of Medical Research. Five-year report (2010- 2014). Sevagram. 2015.

Andrade F, Nakata A, Gotoh N, Fujita A. Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer. Genet Mol Biol. 2020;43(1): e20180269.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marra A, Viale G, Curigliano G. Recent advances in triple negative breast cancer: the immunotherapy era. BMC Med. 2019;17(1):90.

Article  PubMed  PubMed Central  Google Scholar 

Slomovitz BM, Broaddus RR, Burke NS, Soliman PT, Wu W, Sun CC, et al. Her-2/neu overexpression and amplification in uterine papillary serous carcinoma. J Clin Oncol. 2004;22:3126.

Article  CAS  PubMed  Google Scholar 

Zong Y, Pegram M. Research advances and new challenges in overcoming triple-negative breast cancer. Cancer Drug Resist. 2021;4(3):517–42.

CAS  PubMed  PubMed Central  Google Scholar 

Reddy GM, Suresh PK, Pai RR. Clinicopathological features of triple negative breast carcinoma. J Clin Diagn Res. 2017;11(1):05–8.

Google Scholar 

Cocco S, Piezzo M, Calabrese A, Cianniello D, Caputo R, Lauro VD, et al. Biomarkers in triple-negative breast cancer: state-of-the-art and future perspectives. Int J Mol Sci. 2020;21(13):4579.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sarkar S, Akhtar M. Triple negative breast cancer prevalence in Indian patients over a decade: a systematic review. Int J Clin Biostat Biom. 2022;8:045.

Google Scholar 

Bapna A, Patni N, Patni S. Choosing Wisely-Implication based on Indian data in our patients with breast cancer (INR vs. USD). Int J Mol Immuno Oncol. 2021;8(1):6–10.

Article  Google Scholar 

Chintalapani SR, Bala S, Konatam ML, Gundeti S, Kuruva SP, Hui M. Triple-negative breast cancer: pattern of recurrence and survival outcomes. Indian J Med Paediatr Oncol. 2019;40(01):67–72.

Article  Google Scholar 

Yavuz BB, Aktan M, Kanyilmaz G. Prognostic factors in patients with triple negative breast cancer undergoing adjuvant radiotherapy: a 10-year single centre experience: triple negative breast cancer. Arch Breast Cancer. 2022;15:377–85.

Article  Google Scholar 

Bajpai J, Kashyap L, Vallathol DH, Das A, Singh M, Pathak R, et al. Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort. Breast. 2022;63:77–84.

Article  PubMed  PubMed Central  Google Scholar 

Akhtar M, Dasgupta S, Rangwala M. Triple negative breast cancer: an Indian perspective. Breast Cancer (Dove Med Press). 2015;14(7):239–43.

Google Scholar 

Li JW, Zhang K, Shi ZT, Zhang X, Xie J, Liu JY, et al. Triple-negative invasive breast carcinoma: the association between the sonographic appearances with clinicopathological feature. Sci Rep. 2018;8(1):9040.

Article  PubMed  PubMed Central  Google Scholar 

Chandra D, Suresh P, Sinha R, Azam S, Batra U, Talwar V, et al. Eight year survival analysis of patients with triple negative breast cancer in India. Asian Pac J Cancer Prev. 2016;17(6):2995–9.

PubMed  Google Scholar 

Sanges F, Floris M, Cossu-Rocca P, Muroni MR, Pira G, Urru SAM, et al. Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis. BMC Cancer. 2020;20(1):491.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leon-Ferre RA, Polley MY, Liu H, Gilbert JA, Cafourek V, Hillman DW, et al. Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer. Breast Cancer Res Treat. 2018;167(1):89–99.

Article  CAS  PubMed  Google Scholar 

Yao Y, Chu Y, Xu B, Hu Q, Song Q. Risk factors for distant metastasis of patients with primary triple-negative breast cancer. 2019. Biosci Rep. https://doi.org/10.1042/BSR20190288.

Korlimarla A, Hari PS, Prabhu J, Ragulan C, Patil Y, Snijesh VP, Desai K, Mathew A, Appachu S, Diwakar R, Srinath BS. A comprehensive analysis of immune landscape of Indian triple negative breast cancer. bioRxiv. 2022;1(3):75.

Google Scholar 

Anand AS, Joseph A, Stanley A. Pattern of recurrence in radically treated triple negative breast cancer patients. J Cancer Ther. 2021;12(11):611–20.

Article  CAS  Google Scholar 

Alabdulkareem H, Pinchinat T, Khan S, Landers A, Christos P, Simmons R, et al. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy. Breast J. 2018;24(2):148–53.

Article  CAS  PubMed  Google Scholar 

Yin L, Shuang H, Sheng C, Liang H, Sun XJ, Yang WT, et al. The prognostic value of nodal staging in triple-negative breast cancer - a cohort from China. Sci Rep. 2018;8(1):9007.

Article  PubMed  PubMed Central  Google Scholar 

Chen VE, Gillespie EF, Zakeri K, Murphy JD, Yashar CM, Lu S, et al. Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer. Adv Radiat Oncol. 2017;2(2):105–9.

Article  PubMed  PubMed Central  Google Scholar